Ronald J. Buckanovich

Also affiliated with Magee-Womens Research Institute, UPMC Hillman Cancer Center, University of Pittsburgh Medical Center

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 23 papers. Top paper: “Phase II clinical trial of metformin as a cancer stem cell–targeting agent in ovarian cancer”.

Phase II clinical trial of metformin as a cancer stem cell–targeting agent in ovarian cancer

JCI Insight(2020)10.1172/jci.insight.133247

N/A

3.2DataRank · unranked

193 citations

Daniel Chan, Jessica Shank, Kent A. Griffith, Huihui Fan, Robert Szulawski +17 more

Phase I and Randomized Phase II Study of Ruxolitinib With Frontline Neoadjuvant Therapy in Advanced Ovarian Cancer: An NRG Oncology Group Study

Journal of Clinical Oncology(2024)10.1200/jco.23.02076

N/A

0.644DataRank · unranked

20 citations

Ronald J. Buckanovich, Michael W. Sill, Robert S. Mannel, Joan L. Walker, Paul DiSilvestro +13 more

Regulation and pharmacological targeting of RAD51 in cancer

NAR Cancer(2020)10.1093/narcan/zcaa024

N/A

0DataRank · unranked

87 citations

Ronald J. Buckanovich, Kara A. Bernstein, McKenzie K. Grundy

An evolving paradigm of cancer stem cell hierarchies: therapeutic implications

Theranostics(2020)10.7150/thno.41647

N/A

0DataRank · unranked

62 citations

A Fayomi, Vivian I. Anyaeche, Shoumei Bai, Ronald J. Buckanovich, Alexander J. Cole

NFATC4 promotes quiescence and chemotherapy resistance in ovarian cancer

JCI Insight(2020)10.1172/jci.insight.131486

N/A

0DataRank · unranked

52 citations

M. R. S. Iyengar, Santiago Panesso-Gómez, Patrick O’Hayer, Daniel Chan, Greg M. Delgoffe +5 more

Development of 2,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one inhibitors of aldehyde dehydrogenase 1A (ALDH1A) as potential adjuncts to ovarian cancer chemotherapy

European Journal of Medicinal Chemistry(2020)10.1016/j.ejmech.2020.113060

N/A

0DataRank · unranked

15 citations

Edward Grimley, Mikhail Chtcherbinine, Cameron D. Buchman, Cyrus Takahashi, Bikash Debnath +12 more

Immunotherapy Advances for Epithelial Ovarian Cancer

Cancers(2020)10.3390/cancers12123733

N/A

0DataRank · unranked

39 citations

Julia Knight, Mackenzy Radolec, Ronald J. Buckanovich, Robert P. Edwards, Anda Vlad +1 more

The MEK1/2 Pathway as a Therapeutic Target in High-Grade Serous Ovarian Carcinoma

Cancers(2021)10.3390/cancers13061369

N/A

0DataRank · unranked

29 citations

Imran Khan, Yeonjung Park, Jessica Ezell, Geeta Mehta, Abdelrahman Yousif +5 more

Intestinal Radiation Protection and Mitigation by Second-Generation Probiotic Lactobacillus-reuteri Engineered to Deliver Interleukin-22

International Journal of Molecular Sciences(2022)10.3390/ijms23105616

N/A

0DataRank · unranked

33 citations

Michael W. Epperly, Amitava Mukherjee, Renee Fisher, Donna Shields, Hong Wang +14 more

Clinical factors associated with failed sentinel lymph node mapping in endometrial cancer

Gynecologic Oncology Reports(2022)10.1016/j.gore.2022.101080

N/A

0DataRank · unranked

13 citations

Alyssa Wield, Brigid Mumford, Isabel Janmey, Li Wang, Philip J. Grosse +13 more

A phase I/II study of ruxolitinib with frontline neoadjuvant and post-surgical therapy in patients with advanced epithelial ovarian, Fallopian tube, or primary peritoneal cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.5501

N/A

0DataRank · unranked

9 citations

Ronald J. Buckanovich, Michael W. Sill, Robert S. Mannel, Joan L. Walker, Paul DiSilvestro +13 more

Quiescent Ovarian Cancer Cells Secrete Follistatin to Induce Chemotherapy Resistance in Surrounding Cells in Response to Chemotherapy

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-2254

N/A

0DataRank · unranked

25 citations

Santiago Panesso-Gómez, Jaynish S. Shah, Tonge Ebai, Qi Jiang, Ece Gümüşoğlu-Acar +6 more

Generation and characterization of humanized affinity-matured EGFL6 antibodies for ovarian cancer therapy

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.02.004

N/A

0DataRank · unranked

12 citations

A Fayomi, Shoumei Bai, Navneet Gupta, Sandra Cascio, Dongli Yang +2 more

A putative role for ALDH inhibitors and chemoprevention of BRCA-mutation-driven tumors

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.07.015

N/A

0DataRank · unranked

4 citations

Rong Wu, E Grimley, Ekrem Turk, Yali Zhai, Kathleen R. Cho +2 more

Tumor-Associated Macrophages Expand Chemoresistant, Ovarian Cancer Stem-Like Cells

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.07.17.549067

N/A

0DataRank · unranked

1 citations

Madeline Ho, Aakriti Dua, Raquel Buj, Kim Blenman, Sandra Oršulić +4 more

Single-cell analysis reveals the stromal dynamics and tumor-specific characteristics in the microenvironment of ovarian cancer

Communications Biology(2024)10.1038/s42003-023-05733-x

N/A

0DataRank · unranked

38 citations

Sandra Cascio, John W. Mellors, Ronald J. Buckanovich, Hatice U. Osmanbeyoglu, Linan Zhang

Acetate drives ovarian cancer quiescence via ACSS2-mediated acetyl-CoA production

Molecular Metabolism(2024)10.1016/j.molmet.2024.102031

N/A

0DataRank · unranked

6 citations

Emily Megill, Amanda J Chen, Afifa Farooqi, Naveen Kumar Tangudu, Apoorva Uboveja +6 more

Development of substituted benzimidazoles as inhibitors of human aldehyde dehydrogenase 1A isoenzymes

Chemico-Biological Interactions(2024)10.1016/j.cbi.2024.110910

N/A

0DataRank · unranked

4 citations

Mikhail Chtcherbinine, Brandt C. Huddle, Michael W. Wilson, Timothy Emmel, Robert M. Hohlman +5 more

Acetate drives ovarian cancer quiescence via ACSS2-mediated acetyl-CoA production

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.07.12.603313

N/A

0DataRank · unranked

1 citations

Emily Megill, Amanda J Chen, Afifa Farooqi, Stacy McGonigal, Nadine Hempel +4 more

Aged and BRCA -Mutated Stromal Cells Drive Epithelial Cell Transformation

Cancer Discovery(2025)10.1158/2159-8290.cd-24-0805

N/A

0DataRank · unranked

9 citations

Taylor Orellana, Grace Gorecki, Leonard Frisbie, Roja Baruwal, Swathi Suresh +18 more

Murine cell lines with defined mutations model different histological subtypes of epithelial ovarian cancer

Disease Models & Mechanisms(2025)10.1242/dmm.052177

N/A

0DataRank · unranked

0 citations

Yusi Fang, Ibrahim Uygun, Danyang Li, Mary Strange, Syed I. A. Zaidi +12 more

EGFL6 is a novel HER3 ligand, inducing HER3/integrin heterodimers to induce pERK centrosomal deposition and therapeutic resistance

Neoplasia(2025)10.1016/j.neo.2025.101246

N/A

0DataRank · unranked

0 citations

Navneet Gupta, Victoria Liu, A Fayomi, Stacy McGonigal, Ronald J. Buckanovich +1 more

Epigenomic Reprogramming toward Mesenchymal-Epithelial Transition in Ovarian-Cancer-Associated Mesenchymal Stem Cells Drives Metastasis

Cell Reports(2020)10.1016/j.celrep.2020.108473

N/A

0DataRank · unranked

95 citations

Huda I. Atiya, Yeh Wang, Thomas R. Pisanic, Tza‐Huei Wang, Ie‐Ming Shih +10 more